Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature
Roberto Lande, Anna Mennella, Raffaella Palazzo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5102-5102
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein
Andreas Greinacher, Kathleen Selleng, Julia Mayerle, et al.
Blood (2021) Vol. 138, Iss. 14, pp. 1269-1277
Open Access | Times Cited: 113
Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis
Dan Fang, Beidi Chen, Alain Lescoat, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 12, pp. 683-693
Closed Access | Times Cited: 54
Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity
Marie Dominique Ah Kioon, Paôline Laurent, Vidyanath Chaudhary, et al.
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 241-256
Closed Access | Times Cited: 9
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit
Vishal Kakkar, Shervin Assassi, Yannick Allanore, et al.
Current Opinion in Rheumatology (2022) Vol. 34, Iss. 6, pp. 357-364
Open Access | Times Cited: 32
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine
Alain Lescoat, Silvia Bellando-Randone, Corrado Campochiaro, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 11, pp. e683-e694
Open Access | Times Cited: 15
The mosaic of autoimmunity – Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens
Naim Mahroum, Abdulrahman Elsalti, Abdulkarim Alwani, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 10, pp. 103166-103166
Open Access | Times Cited: 20
Molecular Mechanisms Behind the Role of Plasmacytoid Dendritic Cells in Systemic Sclerosis
Inês S. Silva, Beatriz H. Ferreira, Catarina R. Almeida
Biology (2023) Vol. 12, Iss. 2, pp. 285-285
Open Access | Times Cited: 13
Immune and Non-Immune Inflammatory Cells Involved in Autoimmune Fibrosis: New Discoveries
Margherita Sisto, Sabrina Lisi
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3801-3801
Open Access | Times Cited: 12
Undifferentiated connective tissue disease: the diagnoses critically revised - experience of a single center.
Ilaria Cavazzana, Paolo Semeraro, Elena Sofia Kessler, et al.
Research Square (Research Square) (2025)
Closed Access
Distinct metabolic profiles of circulating plasmacytoid dendritic cells in systemic sclerosis patients stratified by clinical phenotypes
Beatriz H. Ferreira, Carolina Mazeda, Eduardo Dourado, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access
Beyond circulating B cells: Characteristics and role of tissue-infiltrating B cells in systemic sclerosis
Mathilde Le Maître, Thomas Guerrier, S. Sangès, et al.
Autoimmunity Reviews (2025) Vol. 24, Iss. 5, pp. 103782-103782
Open Access
The Role of CXCL4 in Systemic Sclerosis: DAMP, Auto-Antigen and Biomarker
Silvia Porreca, Anna Mennella, Loredana Frasca
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2421-2421
Open Access
Biomarkers in Systemic Sclerosis
Claudio Karsulovic, Lía Hojman
Sclerosis (2025) Vol. 3, Iss. 2, pp. 11-11
Open Access
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center
Ilaria Cavazzana, Paolo Semeraro, Cesare Tomasi, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
What have we learned on pre, very early, and early systemic sclerosis microcirculatory pathophysiology? A scoping review
Joana Caetano, Luís Monteiro Rodrigues, José Delgado Alves
Autoimmunity Reviews (2024) Vol. 23, Iss. 5, pp. 103540-103540
Closed Access | Times Cited: 3
CXCL4-RNA Complexes Circulate in Systemic Sclerosis and Amplify Inflammatory/Pro-Fibrotic Responses by Myeloid Dendritic Cells
Immacolata Pietraforte, Alessia Butera, Lucia Gaddini, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 653-653
Open Access | Times Cited: 14
Emerging cellular and immunotherapies for systemic sclerosis: from mesenchymal stromal cells to CAR-T cells and vaccine-based approaches
Alain Lescoat, Hiroshi Kato, John Varga
Current Opinion in Rheumatology (2023) Vol. 35, Iss. 6, pp. 356-363
Closed Access | Times Cited: 8
Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options
Konstantinos Drougkas, Charalampos Skarlis, Clio P. Mavragani
Mediterranean Journal of Rheumatology (2024) Vol. 35, Iss. Suppl 2, pp. 365-365
Open Access | Times Cited: 2
The B-cells paradigm in Systemic Sclerosis: an update on pathophysiology and B-cell targeted therapies
Cristina Scaletti, Sara Pratesi, Silvia Bellando-Randone, et al.
Clinical & Experimental Immunology (2024)
Open Access | Times Cited: 2
CXCL4 deficiency limits M4 macrophage infiltration and attenuates hyperoxia-induced lung injury
Bingrui Yu, Siyuan Jia, Yu Chen, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
The role of B cells in the pathogenesis of systemic sclerosis: an update
Lazaros I. Sakkas, Christina G. Katsiari, Dimitrios Daoussis, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 5, pp. 1780-1786
Closed Access | Times Cited: 11
New Autoantibody Specificities in Systemic Sclerosis and Very Early Systemic Sclerosis
Roberto Lande, Raffaella Palazzo, Anna Mennella, et al.
Antibodies (2021) Vol. 10, Iss. 2, pp. 12-12
Open Access | Times Cited: 13
Treatable Traits in Systemic Sclerosis
Francesco Amati, Gabriele Bongiovanni, Antonio Tonutti, et al.
Clinical Reviews in Allergy & Immunology (2023) Vol. 65, Iss. 2, pp. 251-276
Closed Access | Times Cited: 5
Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis
José Eloy Oller-Rodríguez, Elvira Vicens Bernabeu, Roxana González-Mazarío, et al.
Medicina Clínica (2022) Vol. 159, Iss. 8, pp. 359-365
Closed Access | Times Cited: 9
Dysregulation of Type I Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target?
Minghua Wu, Shervin Assassi
Current Treatment Options in Rheumatology (2021) Vol. 7, Iss. 4, pp. 349-360
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top